by 
The Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 2,400.6 Mn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital breast tomosynthesis (DBT), also known as 3D mammography, is a medical imaging technique that generates 3D images of the breast from multiple X-ray views taken from different angles. DBT equipment helps in early detection of breast cancer by creating high resolution, three-dimensional images through tomosynthesis technology. It provides clearer images of soft tissues in the breast and helps reduce masking effects where structures in the breast overlap. This allows radiologists to better distinguish between abnormalities and normal overlapping tissue.
Market Dynamics:
Two key drivers fueling the growth of the digital breast tomosynthesis equipment market are:
1) Rising prevalence of breast cancer cases: According to the World Cancer Research Fund International, in 2020 around 2.3 million women were diagnosed with breast cancer globally. Growing awareness regarding early screening and diagnosis of breast cancer has increased demand for DBT equipment.
2) Development of advanced DBT systems: Major players are focused on developing and launching new innovative digital breast tomosynthesis equipment with improved imaging features. For instance, in 2020, Hologic Inc. launched 3Dimensions Mammography system featuring upgraded tomo synthesis technology with enhanced CT-like imaging capabilities.
Segment Analysis
The global digital breast tomosynthesis equipment market is dominated by the standalone segment, which held more than 60% market share in 2022. This segment is dominating as digital breast tomosynthesis equipment is majorly used as a standalone device in hospitals and diagnostic centers due to the high adoption of 3D breast imaging technology.
PEST Analysis
Political: Government initiatives to increase awareness about breast cancer screening and increasing healthcare expenditures are expected to drive the market growth.
Economic: Rising per capita healthcare expenditure and technological advancements are the major factors augmenting the growth of the global market.
Social: Increasing prevalence of breast cancer and growing focus on early screening and diagnosis are boosting the demand for digital breast tomosynthesis equipment.
Technological: Ongoing R&D for advanced tomosynthesis systems with improved resolution, higher throughput, and reduced radiation dose is further fueling the market growth.
Key Takeaways
The global digital breast tomosynthesis equipment market is expected to witness high growth, exhibiting a CAGR of 15% over the forecast period, due to increasing healthcare expenditure and prevalence of breast cancer.
The North America region dominated the global market in 2022 and is expected to maintain its dominance during the forecast period. This can be attributed to the presence of major market players, growing adoption of digital breast tomosynthesis for early detection of breast cancer, and favorable insurance reforms in the region.
Key players operating in the digital breast tomosynthesis equipment market size include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation. Major players are focusing on new product launches and regional expansion to strengthen their market presence. For instance, in January 2020, Hologic launched its 3Dimensions breast tomosynthesis system in India, expanding its global footprint.
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
